Page 16 - Nasdaq Cert News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The PMDA enters 9th consecutive year of using Certara’s software...

Certara (NASDAQ:CERT – Get Rating) and Workiva (NYSE:WK – Get Rating) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, valuation, dividends, analyst recommendations and risk. Profitability This table compares Certara and Workiva’s net margins, return on […]

Certara (NASDAQ:CERT – Get Rating) and SPS Commerce (NASDAQ:SPSC – Get Rating) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, profitability, analyst recommendations, risk and valuation. Insider & Institutional Ownership 52.1% of Certara shares are owned […]

Certara (NASDAQ:CERT – Get Rating) updated its FY 2022 earnings guidance on Monday. The company provided earnings per share guidance of $0.48-$0.53 for the period, compared to the consensus earnings per share estimate of $0.44. The company issued revenue guidance of $350.00 million-$360.00 million, compared to the consensus revenue estimate of $355.92 million. Several equities […]

Wall Street analysts predict that Certara, Inc. (NASDAQ:CERT – Get Rating) will post $85.32 million in sales for the current fiscal quarter, according to Zacks. Two analysts have made estimates for Certara’s earnings. The highest sales estimate is $85.33 million and the lowest is $85.30 million. Certara posted sales of $70.10 million in the same […]